LAMAX
Price
$24.46
Change
-$0.08 (-0.33%)
Updated
Nov 14 closing price
VTSAX
Price
$143.16
Change
-$0.98 (-0.68%)
Updated
Nov 14 closing price
Ad is loading...

LAMAX vs VTSAX

Header iconLAMAX vs VTSAX Comparison
Open Charts LAMAX vs VTSAXBanner chart's image
Lord Abbett Dividend Growth A
Price$24.46
Change-$0.08 (-0.33%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$143.16
Change-$0.98 (-0.68%)
VolumeN/A
CapitalizationN/A
LAMAX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAMAX vs. VTSAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAMAX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. LAMAX (4.38B). VTSAX pays higher dividends than LAMAX: VTSAX (1.35) vs LAMAX (0.73). LAMAX was incepted earlier than VTSAX: LAMAX (23 years) vs VTSAX (24 years). LAMAX is a more actively managed with annual turnover of: 35.00 vs. VTSAX (2.00). LAMAX has a lower initial minimum investment than VTSAX: LAMAX (1000) vs VTSAX (3000). VTSAX (33.39) and LAMAX (32.85) have marching annual gain over last year. VTSAX return over 5 years is better than : 87.46 vs. LAMAX (54.05).
LAMAXVTSAXLAMAX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD27.06924.891109%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.38B1.73T0%
Annual Yield % from dividends0.731.3554%
Returns for 1 year32.8533.3998%
Returns for 3 years14.1622.8262%
Returns for 5 years54.0587.4662%
Returns for 10 years59.36194.0731%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals